Surgepays Stock Buy Hold or Sell Recommendation
| SURG Stock | USD 1.80 0.09 4.76% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Surgepays is 'Strong Sell'. Macroaxis provides Surgepays buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding SURG positions.
Check out Surgepays Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide. Note, we conduct extensive research on individual companies such as Surgepays and provide practical buy, sell, or hold advice based on investors' constraints. Surgepays. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Surgepays |
Execute Surgepays Buy or Sell Advice
The Surgepays recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Surgepays. Macroaxis does not own or have any residual interests in Surgepays or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Surgepays' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Extremely Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Surgepays Trading Alerts and Improvement Suggestions
| Surgepays is way too risky over 90 days horizon | |
| Surgepays may become a speculative penny stock | |
| Surgepays appears to be risky and price may revert if volatility continues | |
| About 32.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: SurgePays ClearLine Marketing Platform Integrates with Clover Point of Sale System |
Surgepays Returns Distribution Density
The distribution of Surgepays' historical returns is an attempt to chart the uncertainty of Surgepays' future price movements. The chart of the probability distribution of Surgepays daily returns describes the distribution of returns around its average expected value. We use Surgepays price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Surgepays returns is essential to provide solid investment advice for Surgepays.
| Mean Return | 0.54 | Value At Risk | -7.26 | Potential Upside | 14.29 | Standard Deviation | 6.03 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Surgepays historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Surgepays Stock Institutional Investors
| Shares | Corsair Capital Management Llc | 2024-09-30 | 29.9 K | Cetera Investment Advisers | 2024-09-30 | 22.2 K | Two Sigma Securities, Llc | 2024-09-30 | 19.3 K | Royce & Associates, Lp | 2024-09-30 | 18.6 K | James Investment Research, Inc. | 2024-09-30 | 13 K | Goss Wealth Management Llc | 2024-09-30 | 13 K | Susquehanna International Group, Llp | 2024-09-30 | 12.1 K | Simplex Trading, Llc | 2024-09-30 | 8 K | Ubs Group Ag | 2024-09-30 | 4.3 K | Vanguard Group Inc | 2024-09-30 | 587 K | Cable Car Capital Llc | 2024-09-30 | 515 K |
Surgepays Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (98.6K) | 328.0K | 5.6M | 752.2K | 7.6M | 8.0M | |
| Free Cash Flow | (6.8M) | (4.3M) | (15.3M) | 94.7K | 10.0M | 10.5M | |
| Other Non Cash Items | 505.2K | (628.2K) | 2.2M | 26.1M | 1.9M | 2.7M | |
| Capital Expenditures | 227.6K | 6.6K | 51.4K | 698.6K | 281.3K | 295.4K | |
| Net Income | (8.4M) | (10.7M) | (13.5M) | (553.2K) | 20.6M | 21.6M | |
| End Period Cash Flow | 346.0K | 674.0K | 6.3M | 7.0M | 14.6M | 15.4M | |
| Change To Inventory | 2.1M | (178.3K) | (4.3M) | (6.9M) | 2.1M | 2.2M | |
| Depreciation | 282.9K | 1.4M | 917.5K | 988.7K | 1.1M | 1.2M | |
| Investments | (32.2K) | 15.0K | (376.7K) | (1.5M) | (281.3K) | (295.4K) | |
| Net Borrowings | 3.3M | 4.1M | 2.2M | 1.5M | 1.7M | 1.5M |
Surgepays Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Surgepays or Wireless Telecommunication Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Surgepays' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Surgepays stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.29 | |
β | Beta against Dow Jones | 2.08 | |
σ | Overall volatility | 6.16 | |
Ir | Information ratio | 0.07 |
Surgepays Volatility Alert
Surgepays is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Surgepays' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Surgepays' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Surgepays Fundamentals Vs Peers
Comparing Surgepays' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Surgepays' direct or indirect competition across all of the common fundamentals between Surgepays and the related equities. This way, we can detect undervalued stocks with similar characteristics as Surgepays or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Surgepays' fundamental indicators could also be used in its relative valuation, which is a method of valuing Surgepays by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Surgepays to competition |
| Fundamentals | Surgepays | Peer Average |
| Return On Equity | -0.0519 | -0.31 |
| Return On Asset | -0.0151 | -0.14 |
| Profit Margin | (0.01) % | (1.27) % |
| Operating Margin | (0.72) % | (5.51) % |
| Current Valuation | 17.66 M | 16.62 B |
| Shares Outstanding | 20.16 M | 571.82 M |
| Shares Owned By Insiders | 31.90 % | 10.09 % |
| Shares Owned By Institutions | 8.72 % | 39.21 % |
| Number Of Shares Shorted | 361.27 K | 4.71 M |
| Price To Earning | 11.14 X | 28.72 X |
| Price To Book | 1.11 X | 9.51 X |
| Price To Sales | 0.34 X | 11.42 X |
| Revenue | 137.14 M | 9.43 B |
| Gross Profit | 13.47 M | 27.38 B |
| EBITDA | 20.08 M | 3.9 B |
| Net Income | 20.62 M | 570.98 M |
| Cash And Equivalents | 8.7 M | 2.7 B |
| Cash Per Share | 0.70 X | 5.01 X |
| Total Debt | 5.44 M | 5.32 B |
| Debt To Equity | 6.32 % | 48.70 % |
| Current Ratio | 1.07 X | 2.16 X |
| Book Value Per Share | 1.96 X | 1.93 K |
| Cash Flow From Operations | 10.29 M | 971.22 M |
| Short Ratio | 3.13 X | 4.00 X |
| Earnings Per Share | (1.18) X | 3.12 X |
| Price To Earnings To Growth | 0.53 X | 4.89 X |
| Target Price | 6.0 | |
| Number Of Employees | 22 | 18.84 K |
| Beta | 1.39 | -0.15 |
| Market Capitalization | 38.11 M | 19.03 B |
| Total Asset | 41.93 M | 29.47 B |
| Retained Earnings | (15.19 M) | 9.33 B |
| Working Capital | 20.66 M | 1.48 B |
Note: Disposition of 36666 shares by Evers Anthony George of Surgepays at 1.86 subject to Rule 16b-3 [view details]
Surgepays Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Surgepays . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 16304.47 | |||
| Daily Balance Of Power | (0.75) | |||
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 1.81 | |||
| Day Typical Price | 1.81 | |||
| Price Action Indicator | (0.06) | |||
| Period Momentum Indicator | (0.09) |
About Surgepays Buy or Sell Advice
When is the right time to buy or sell Surgepays? Buying financial instruments such as Surgepays Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Surgepays in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Processed Foods Thematic Idea Now
Processed Foods
Companies producing and distributing processed foods to retail sectors. The Processed Foods theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Processed Foods Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Surgepays Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Wireless Telecommunication Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.78) | Earnings Share (1.18) | Revenue Per Share 6.864 | Quarterly Revenue Growth (0.58) | Return On Assets (0.02) |
The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.